Douglas Laboratories Corvalen
D-Ribose is a natural pentose sugar that is the backbone of the ATP molecular structure which supports the body's natural energy production. D-ribose in ATP (adenosine triphosphate) is naturally present in every living cell in our body. D-ribose powder is highly soluble in either hot or cold solutions and tastes slightly sweet.
Each serving contains:
Calories - 20
Total Carbohydrate - 5 g
Sugars - 5 g
D-Ribose - 5 g
Other ingredients: None.
1 scoop (2 teaspoons) is equivalent to 5 grams. Normal dosage is 5 grams D-Ribose taken two times a day with the morning and evening meals. A third dose may be added at midday as needed, or as directed by your healthcare professional. Continued use is required to maintain the benefits of Corvalen.
Corvalen® contains pure D-ribose, a safe and clinically researched ingredient that supports the natural way our bodies produce adenosine triphosphate (ATP), the energy currency of the cell. Ribose is the vital structural backbone of critical cellular compounds called purines and pyrimidines. Our bodies must have an adequate supply of purines and pyrimidines to form major cellular constituents such as our genetic material (DNA and RNA), numerous cofactors, certain vitamins, and, importantly, adenosine triphosphate (ATP). Ribose is the starting point for the synthesis of these fundamental cellular compounds, and the availability of ribose determines the rate at which they can be made by our cells and tissues.D-ribose is a structural component of DNA, RNA, ATP, GTP, flavins (FAD, riboflavin) and other important nucleotides found in all living cells.
Ribose is formed naturally via the pentose phosphate pathway. This pathway is slow and rate-limited in cardiac and skeletal muscle due to an inherently low concentration (lack of expression) of the enzymes, glucose-6- phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. The product of this pathway is ribose-5- phosphate, which in turn is converted to 5-phosphoribosyl-1-pyrophosphate (PRPP), the primary driver in the synthesis and salvage of purine nucleotides. No other compound can be used by the body for this metabolic purpose. Purine nucleotides (ATP and its precursors) lost due to ischemia, hypoxia, or genetic predisposition are replaced via the purine nucleotide pathway. This pathway is rate limited by the availability of ribose in tissue. Administration of exogenous ribose bypasses the rate-limiting steps in the pentose phosphate pathway, resulting in a significant acceleration of PRPP.